Annual Total Debt
$0.00
-$8400.00-100.00%
31 December 2023
Summary:
Monopar Therapeutics annual total debt is currently $0.00, with the most recent change of -$8400.00 (-100.00%) on 31 December 2023. During the last 3 years, it has risen by $0.00 (0.00%). MNPR annual total debt is now -100.00% below its all-time high of $8400.00, reached on 31 December 2022.MNPR Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Debt
$0.00
$0.000.00%
30 September 2024
Summary:
Monopar Therapeutics quarterly total debt is currently $0.00, unchanged on 30 September 2024. Over the past year, it has stayed the same.MNPR quarterly total debt is now -100.00% below its all-time high of $122.40 thousand, reached on 30 June 2020.MNPR Quarterly Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MNPR Total Debt Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -100.0% | 0.0% |
| 3 y3 years | 0.0% | 0.0% |
| 5 y5 years | 0.0% | 0.0% |
MNPR Total Debt High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -100.0% | -100.0% | ||
| 5 y | 5 years | -100.0% | -100.0% | ||
| alltime | all time | -100.0% | -100.0% |
Monopar Therapeutics Total Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $0.00(0.0%) |
| June 2024 | - | $0.00(0.0%) |
| Mar 2024 | - | $0.00(0.0%) |
| Dec 2023 | $0.00(-100.0%) | $0.00(0.0%) |
| Sept 2023 | - | $0.00(0.0%) |
| June 2023 | - | $0.00(0.0%) |
| Mar 2023 | - | $0.00(-100.0%) |
| Dec 2022 | $8400.00(>+9900.0%) | $8400.00(-59.8%) |
| Sept 2022 | - | $20.90 K(-36.9%) |
| June 2022 | - | $33.10 K(+30.8%) |
| Mar 2022 | - | $25.30 K(>+9900.0%) |
| Dec 2021 | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2021 | - | $0.00(0.0%) |
| June 2021 | - | $0.00(0.0%) |
| Mar 2021 | - | $0.00(0.0%) |
| Dec 2020 | $0.00 | $0.00(-100.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2020 | - | $122.40 K(0.0%) |
| June 2020 | - | $122.40 K(>+9900.0%) |
| Mar 2020 | - | $0.00(0.0%) |
| Dec 2019 | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2019 | - | $0.00(0.0%) |
| June 2019 | - | $0.00(0.0%) |
| Mar 2019 | - | $0.00(0.0%) |
| Dec 2018 | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2018 | - | $0.00(0.0%) |
| June 2018 | - | $0.00(0.0%) |
| Mar 2018 | - | $0.00(0.0%) |
| Dec 2017 | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2017 | - | $0.00(0.0%) |
| June 2017 | - | $0.00(0.0%) |
| Mar 2017 | - | $0.00 |
| Dec 2016 | $0.00 | - |
FAQ
- What is Monopar Therapeutics annual total debt?
- What is the all time high annual total debt for Monopar Therapeutics?
- What is Monopar Therapeutics annual total debt year-on-year change?
- What is Monopar Therapeutics quarterly total debt?
- What is the all time high quarterly total debt for Monopar Therapeutics?
- What is Monopar Therapeutics quarterly total debt year-on-year change?
What is Monopar Therapeutics annual total debt?
The current annual total debt of MNPR is $0.00
What is the all time high annual total debt for Monopar Therapeutics?
Monopar Therapeutics all-time high annual total debt is $8400.00
What is Monopar Therapeutics annual total debt year-on-year change?
Over the past year, MNPR annual total debt has changed by -$8400.00 (-100.00%)
What is Monopar Therapeutics quarterly total debt?
The current quarterly total debt of MNPR is $0.00
What is the all time high quarterly total debt for Monopar Therapeutics?
Monopar Therapeutics all-time high quarterly total debt is $122.40 K
What is Monopar Therapeutics quarterly total debt year-on-year change?
Over the past year, MNPR quarterly total debt has changed by $0.00 (0.00%)